Počet záznamů: 1
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use
- 1.0559932 - ÚOCHB 2023 RIV eng P - Patentový dokument
Hocek, Michal - Tichý, Michal - Hajdúch, M. - Džubák, P.
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use.
2022. Vlastník: Ústav organické chemie a biochemie AV ČR, v. v. i. – Univerzita Palackého v Olomouci. Datum udělení patentu: 10.08.2022. Číslo patentu: EP3478701
Grant CEP: GA TA ČR(CZ) TE01020028; GA ČR(CZ) GA16-00178S; GA MZd(CZ) NV15-31984A
Institucionální podpora: RVO:61388963
Klíčová slova: nucleosides * fused heterocycles * cytostatics
Obor OECD: Medicinal chemistry
https://worldwide.espacenet.com/patent/search/family/056550662/publication/EP3478701B1?q=EP3478701B1
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use The invention provides a new group of substituted thienopyrrolopyrimidine ribonucleosides of general formula I, wherein R is defined in the claims. The compounds of this invention show strong cytostatic and cytotoxic activities preferably against cancer cell lines of broad spectrum of diseases including tumors of various histogenetic origin.
Trvalý link: https://hdl.handle.net/11104/0333049
Počet záznamů: 1